Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979327 · ClinicalTrials.gov registry record · Phase 4
Cardiovascular Effects of Adderall in Healthy Adults.
A Phase 4 study of Cardiovascular System and Hemodynamics, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02979327: Completed Phase 4 study of Cardiovascular System and Hemodynamics, sponsored by Mayo Clinic.
NCT02979327 is a Phase 4 study of Cardiovascular System and Hemodynamics that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02979327, a Phase 4 study of Cardiovascular System and Hemodynamics, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.
Primary Outcome
Systolic blood pressure (top number of blood pressure reading)
Conditions Studied
Interventions
- DRUG Placebo capsule
- DRUG Adderall capsule
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-07-23 |
| Phase | Phase 4 |
What the finished NCT02979327 record still lists
NCT02979327 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Cardiovascular System appearing as the primary indexed condition, and to 2 interventions - of which Placebo capsule is the first listed.
NCT02979327 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02979327 about?
NCT02979327 is a clinical study titled "Cardiovascular Effects of Adderall in Healthy Adults.". This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.
What is the current status of trial NCT02979327?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2018-06-01. Estimated completion is 2021-07-23.
What conditions does trial NCT02979327 study?
This clinical trial studies the following conditions: Cardiovascular System, Hemodynamics.
What interventions are being tested in trial NCT02979327?
The interventions under investigation include: Placebo capsule (DRUG), Adderall capsule (DRUG).
Who is sponsoring clinical trial NCT02979327?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02979327 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular System
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02979327's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI